BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang J, Wolters JE, van Breda SG, Kleinjans JC, de Kok TM. Development of novel tools for the in vitro investigation of drug-induced liver injury. Expert Opin Drug Metab Toxicol. 2015;11:1523-1537. [PMID: 26155718 DOI: 10.1517/17425255.2015.1065814] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Milner E, Ainsworth M, Mcdonough M, Stevens B, Buehrer J, Delzell R, Wilson C, Barnhill J. Emerging Three-Dimensional Hepatic Models in Relation to Traditional Two-Dimensional In Vitro Assays for Evaluating Drug Metabolism and Hepatoxicity. Medicine in Drug Discovery 2020;8:100060. [DOI: 10.1016/j.medidd.2020.100060] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Rosato A, Tenori L, Cascante M, De Atauri Carulla PR, Martins Dos Santos VAP, Saccenti E. From correlation to causation: analysis of metabolomics data using systems biology approaches. Metabolomics 2018;14:37. [PMID: 29503602 DOI: 10.1007/s11306-018-1335-y] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 21.3] [Reference Citation Analysis]
3 Lam D, Luu PL, Song JZ, Qu W, Risbridger GP, Lawrence MG, Lu J, Trau M, Korbie D, Clark SJ, Pidsley R, Stirzaker C. Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels. Clin Epigenetics 2020;12:90. [PMID: 32571390 DOI: 10.1186/s13148-020-00880-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Ricard-blum S, Miele AE. Omic approaches to decipher the molecular mechanisms of fibrosis, and design new anti-fibrotic strategies. Seminars in Cell & Developmental Biology 2020;101:161-9. [DOI: 10.1016/j.semcdb.2019.12.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Peng Z, Chen L, Nüssler AK, Liu L, Yang W. Current sights for mechanisms of deoxynivalenol-induced hepatotoxicity and prospective views for future scientific research: A mini review: DON-induced hepatotoxicity and prospective views. J Appl Toxicol 2017;37:518-29. [DOI: 10.1002/jat.3428] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
6 Funk C, Roth A. Current limitations and future opportunities for prediction of DILI from in vitro. Arch Toxicol 2017;91:131-42. [DOI: 10.1007/s00204-016-1874-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
7 Fischer N, Efferth T, Niki E, Capanoglu E, Sieniawska E. The impact of “omics” technologies for grapevine (Vitis vinifera) research. JBR 2021;11:567-81. [DOI: 10.3233/jbr-200633] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wolters JEJ, van Breda SGJ, Caiment F, Claessen SM, de Kok TMCM, Kleinjans JCS. Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes. Chem Res Toxicol 2017;30:1847-54. [PMID: 28853863 DOI: 10.1021/acs.chemrestox.7b00171] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
9 Hadjittofi C, Feretis M, Martin J, Harper S, Huguet E. Liver regeneration biology: Implications for liver tumour therapies. World J Clin Oncol 2021; 12(12): 1101-1156 [DOI: 10.5306/wjco.v12.i12.1101] [Reference Citation Analysis]
10 Vinken M. Omics-based input and output in the development and use of adverse outcome pathways. Current Opinion in Toxicology 2019;18:8-12. [DOI: 10.1016/j.cotox.2019.02.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
11 Fernando RN, Chaudhari U, Escher SE, Hengstler JG, Hescheler J, Jennings P, Keun HC, Kleinjans JCS, Kolde R, Kollipara L, Kopp-Schneider A, Limonciel A, Nemade H, Nguemo F, Peterson H, Prieto P, Rodrigues RM, Sachinidis A, Schäfer C, Sickmann A, Spitkovsky D, Stöber R, van Breda SGJ, van de Water B, Vivier M, Zahedi RP, Vinken M, Rogiers V. "Watching the Detectives" report of the general assembly of the EU project DETECTIVE Brussels, 24-25 November 2015. Arch Toxicol 2016;90:1529-39. [PMID: 27129694 DOI: 10.1007/s00204-016-1719-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Gómez-Lechón MJ, Tolosa L, Donato MT. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs. J Appl Toxicol 2016;36:752-68. [PMID: 26691983 DOI: 10.1002/jat.3277] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
13 Mosedale M, Watkins PB. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management. Clin Pharmacol Ther 2017;101:469-80. [PMID: 27861792 DOI: 10.1002/cpt.564] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 18.2] [Reference Citation Analysis]
14 Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nat Rev Drug Discov 2020;19:131-48. [DOI: 10.1038/s41573-019-0048-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 16.0] [Reference Citation Analysis]
15 Furihata C, Watanabe T, Suzuki T, Hamada S, Nakajima M. Collaborative studies in toxicogenomics in rodent liver in JEMS·MMS; a useful application of principal component analysis on toxicogenomics. Genes Environ 2016;38:15. [PMID: 27482301 DOI: 10.1186/s41021-016-0041-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
16 Ntamo Y, Ziqubu K, Chellan N, Nkambule BB, Nyambuya TM, Mazibuko-Mbeje SE, Gabuza KB, Marcheggiani F, Tiano L, Dludla PV. Drug-Induced Liver Injury: Clinical Evidence of N-Acetyl Cysteine Protective Effects. Oxid Med Cell Longev 2021;2021:3320325. [PMID: 34912495 DOI: 10.1155/2021/3320325] [Reference Citation Analysis]
17 Zeilinger K, Freyer N, Damm G, Seehofer D, Knöspel F. Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood) 2016;241:1684-98. [PMID: 27385595 DOI: 10.1177/1535370216657448] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 12.3] [Reference Citation Analysis]
18 Sajjad H, Imtiaz S, Noor T, Siddiqui YH, Sajjad A, Zia M. Cancer models in preclinical research: A chronicle review of advancement in effective cancer research. Animal Model Exp Med 2021;4:87-103. [PMID: 34179717 DOI: 10.1002/ame2.12165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jeong CG, Dal Negro G, Getsios S, Ekert JE. Application of complex in vitro models (CIVMs) in drug discovery for safety testing and disease modeling. Microfluidic Cell Culture Systems. Elsevier; 2019. pp. 121-58. [DOI: 10.1016/b978-0-12-813671-3.00005-0] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sun S, Wang M, Yuan Y, Wang S, Ding H, Liang C, Li X, Fan S, Li Y. A new strategy for the rapid identification and validation of direct toxicity targets of psoralen-induced hepatotoxicity. Toxicol Lett 2022:S0378-4274(22)00090-X. [PMID: 35597499 DOI: 10.1016/j.toxlet.2022.05.002] [Reference Citation Analysis]
21 Hiemstra S, Ramaiahgari SC, Wink S, Callegaro G, Coonen M, Meerman J, Jennen D, van den Nieuwendijk K, Dankers A, Snoeys J, de Bont H, Price L, van de Water B. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability. Arch Toxicol 2019;93:2895-911. [DOI: 10.1007/s00204-019-02552-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
22 Desaulniers D, Vasseur P, Jacobs A, Aguila MC, Ertych N, Jacobs MN. Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications. Int J Mol Sci 2021;22:10969. [PMID: 34681626 DOI: 10.3390/ijms222010969] [Reference Citation Analysis]
23 Yan L, Messner CJ, Tian M, Gou X, Suter-Dick L, Zhang X. Evaluation of dioxin induced transcriptomic responses in a 3D human liver microtissue model. Environ Res 2022;:112906. [PMID: 35181307 DOI: 10.1016/j.envres.2022.112906] [Reference Citation Analysis]
24 Weaver RJ, Betts C, Blomme EAG, Gerets HHJ, Gjervig Jensen K, Hewitt PG, Juhila S, Labbe G, Liguori MJ, Mesens N, Ogese MO, Persson M, Snoeys J, Stevens JL, Walker T, Park BK. Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.Expert Opin Drug Metab Toxicol. 2017;13:767-782. [PMID: 28604124 DOI: 10.1080/17425255.2017.1341489] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
25 Jiang J, Pieterman CD, Ertaylan G, Peeters RLM, de Kok TMCM. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro. Arch Toxicol 2019;93:3067-98. [PMID: 31586243 DOI: 10.1007/s00204-019-02585-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
26 Mosedale M, Watkins PB. Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury. J Med Chem 2020;63:6436-61. [PMID: 32037821 DOI: 10.1021/acs.jmedchem.9b01297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
27 Mirahmad M, Sabourian R, Mahdavi M, Larijani B, Safavi M. In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation. Drug Metab Rev 2022;:1-76. [PMID: 35403528 DOI: 10.1080/03602532.2022.2064487] [Reference Citation Analysis]
28 Cuypers ML, Chanteux H, Gillent E, Bonnaillie P, Saunders K, Beckers C, Delatour C, Dell'Aiera S, Ungell AL, Nicolaï J. (-)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes. Drug Metab Dispos 2020;48:1121-8. [PMID: 32839278 DOI: 10.1124/dmd.120.000089] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Lin C, Khetani SR. Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury. Biomed Res Int 2016;2016:1829148. [PMID: 27725933 DOI: 10.1155/2016/1829148] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
30 Ciano-Petersen NL, Cabezudo-García P, Muñiz-Castrillo S, Honnorat J, Serrano-Castro PJ, Oliver-Martos B. Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Int J Mol Sci 2021;22:13127. [PMID: 34884930 DOI: 10.3390/ijms222313127] [Reference Citation Analysis]
31 Jellali R, Lereau Bernier M, Tauran Y, Gilard F, Danoy M, Kido T, Miyajima A, Sakai Y, Leclerc E. Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. Differentiation 2020;112:17-26. [PMID: 31869687 DOI: 10.1016/j.diff.2019.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Atienzar FA, Blomme EA, Chen M, Hewitt P, Kenna JG, Labbe G, Moulin F, Pognan F, Roth AB, Suter-Dick L, Ukairo O, Weaver RJ, Will Y, Dambach DM. Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans. Biomed Res Int 2016;2016:9737920. [PMID: 27689095 DOI: 10.1155/2016/9737920] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
33 Raschi E, De Ponti F. Drug-induced liver injury: Towards early prediction and risk stratification. World J Hepatol 2017; 9(1): 30-37 [PMID: 28105256 DOI: 10.4254/wjh.v9.i1.30] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
34 Raddatz BB, Spitzbarth I, Matheis KA, Kalkuhl A, Deschl U, Baumgärtner W, Ulrich R. Microarray-Based Gene Expression Analysis for Veterinary Pathologists: A Review. Vet Pathol 2017;54:734-55. [PMID: 28641485 DOI: 10.1177/0300985817709887] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
35 Jiang J, Messner S, Kelm J, van Herwijnen M, Jennen D, Kleinjans J, de Kok T. Human 3D multicellular microtissues: An upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity. Toxicology Letters 2019;312:34-44. [DOI: 10.1016/j.toxlet.2019.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
36 Huang D, Zhang X, Fu X, Zu Y, Sun W, Zhao Y. Liver spheroids on chips as emerging platforms for drug screening. Engineered Regeneration 2021;2:246-56. [DOI: 10.1016/j.engreg.2021.10.003] [Reference Citation Analysis]